BUSINESS

• JCR to Roll Out Cell Therapy Temcell on Feb. 24; Medipal to Be Exclusive Distributor
  February 18, 2016

• Genzyme Japan to Be Merged into Sanofi in July
  February 17, 2016

• Eisai, Sysmex Link Up in Next-Gen Diagnostic Reagents for Dementia
  February 16, 2016

• Shionogi Joins Cambridge Therapeutic Consortium
  February 16, 2016

• Asahi Kasei, Pfizer Wind Up Recomodulin Copromotion Scheme
  February 16, 2016

• Otsuka’s Pharma Sales Down Nearly 15% in 2015
  February 15, 2016

• Pfizer’s Metformin 500 mg Fails to Clear Test, Shipment Suspended
  February 15, 2016

• Astellas Completes Acquisition of Ocata
  February 15, 2016

• Alecensa Japan PIII Trial Halted Early for Benefit
  February 12, 2016

• Lilly’s Japan Sales Slip 2% to US$1.9 Billion in 2015
  February 12, 2016

• Sakigake: Now and Future (2) - Shionogi Aims to Submit Application for Novel Flu Drug as Early as FY2017
  February 12, 2016

• New CSL Japan Chief Eager to See Annual Sales of 40 Billion Yen in 5 Years
  February 10, 2016

• Asahi Kasei President to Step Down over Piling Data Scandal
  February 10, 2016

• Daiichi Sankyo to Close UK Development Unit
  February 10, 2016

• Otsuka Licenses US Rights for PDE4 Inhibitor to Medimetriks
  February 10, 2016

• Ethical Drug Sales Up 5.7% in December: Crecon Report
  February 10, 2016

• Gilead, Bristol Take Quantum Leaps in 2015, Lilly Logs Double-Digit Growth: IMS
  February 10, 2016

• Japan Sales of “Huge Seller” Quartet Each Break 110 Billion Yen in 2015: IMS
  February 10, 2016

• Mundipharma Gearing Up for Full-Blown Oncology Business in Japan
  February 9, 2016

• AZ Posts Japan Sales of US$2 Billion in 2015, Down 9% in Actual Terms
  February 9, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 492
• 493
• 494
• 495
• 496
• 497
• 498
• 499
• 500
• …
• Next ›
• 最終 »